| Report ID | Date of report | Patient age | Patient gender |
| 132072 | Jun, 8, 2006 | 51 | Female |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Arava | leflunomide |
Prednisolone | prednisolone |
| Name |
Alanine Aminotransferase Decreased |
Aspartate Aminotransferase Increased |
Biopsy Skin Abnormal |
Hepatic Function Abnormal |
Pyrexia |
Stevens-johnson Syndrome |
Toxic Epidermal Necrolysis |
Results from eHealthMe : 1584 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Alanine Aminotransferase Decreased | 2 (0.13%) |
Aspartate Aminotransferase Increased | 234 (14.77%) |
Biopsy Skin Abnormal | 3 (0.19%) |
Hepatic Function Abnormal | 95 (6.00%) |
Pyrexia | 127 (8.02%) |
Stevens-johnson Syndrome | 3 (0.19%) |
Toxic Epidermal Necrolysis | 4 (0.25%) |
Top 3 (total: 668. Click here to see more) co-used drugs - potential interacting drugs:
| Name | Count (% of total co-drugs) |
Methotrexate | 528 (5.12%) |
Humira | 348 (3.37%) |
Remicade | 222 (2.15%) |
Death reported: 17 (1.07% of total reports)
| Name | Count (% of total reports) |
Alanine Aminotransferase Increased | 240 (15.15%) |
Aspartate Aminotransferase Increased | 234 (14.77%) |
Gamma-glutamyltransferase Increased | 166 (10.48%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports:
